Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K M Bruce

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Journal of the National Cancer Institute|September 1, 1985
Evidence for an anticomplementary factor associated with human bone marrow cellsA P Gee, K M Bruce, T D Morris, et al.
Regulatory Toxicology and Pharmacology : RTP|February 3, 1999
A survey of lead-based paint abatement projects performed in public buildings in Erie and Crawford Counties, Pennsylvania, during the time period 1995-1997J H Lange, K M Bruce, R L Johnson, et al.
Journal of the National Cancer Institute|January 1, 1987
Selective loss of expression of a tumor-associated antigen on a human leukemia cell line induced by treatment with monoclonal antibody and complementA P Gee, K M Bruce, J van Hilten, et al.
Chemotherapy|July 30, 2004
Chemotherapy delays progression of motor neuron disease in the SOD1 G93A transgenic mouseK M Bruce, K Narayan, H C Kong, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Journal of the National Cancer Institute|September 1, 1985
Evidence for an anticomplementary factor associated with human bone marrow cellsA P Gee, K M Bruce, T D Morris, et al.
Regulatory Toxicology and Pharmacology : RTP|February 3, 1999
A survey of lead-based paint abatement projects performed in public buildings in Erie and Crawford Counties, Pennsylvania, during the time period 1995-1997J H Lange, K M Bruce, R L Johnson, et al.
Journal of the National Cancer Institute|January 1, 1987
Selective loss of expression of a tumor-associated antigen on a human leukemia cell line induced by treatment with monoclonal antibody and complementA P Gee, K M Bruce, J van Hilten, et al.
Chemotherapy|July 30, 2004
Chemotherapy delays progression of motor neuron disease in the SOD1 G93A transgenic mouseK M Bruce, K Narayan, H C Kong, et al.
Pageof 1